Clinical Trials Logo

Clinical Trial Summary

Treatment of PKU implies for most patients that with strict adherence to dietary treatment they can achieve excellent neurocognitive outcome. Dietary treatment, though, is hard to comply to every day and with every single meal. Unsurprisingly, health-related quality of life (HrQol) is negatively affected if patients have to follow a dietary regime of this kind. Adherence to treatment in PKU is very variable. Factors of significant impact on adherence to treatment and well-being in chronic disease such as self-efficacy or parenting stress have not yet been widely investigated in PKU patients. The ideal treatment prescription (and guideline) recommends as much as necessary and as little as possible, based on the best evidence available. Patients should neither be deprived of treatment options nor be exposed to overtreatment. This study investigates adherence, metabolic control, HrQol in PKU patients treated by centres which follow different guidelines


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05128149
Study type Observational
Source University Children's Hospital, Zurich
Contact Martina Huemer, Prof
Phone +41 44 2660
Email [email protected]
Status Not yet recruiting
Phase
Start date November 15, 2021
Completion date November 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04898829 - Evaluation of PKU Explore France N/A
Not yet recruiting NCT04433728 - Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.
Completed NCT01209819 - Bone Mineral Density in Adults With Hyperphenylalaninemia N/A
Not yet recruiting NCT04969809 - Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients N/A
Not yet recruiting NCT04272736 - PKU Low Calorie Drink Study N/A
Recruiting NCT04404530 - Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
Completed NCT04368624 - PKU Skin Stripping
Recruiting NCT04452513 - A Prospective Clinical Study of Phenylketonuria (PKU)
Not yet recruiting NCT05096988 - Evaluation of PKU Sphere Liquid N/A
Recruiting NCT04943393 - Remote Neurocognitive and Psychological Assessment in PKU
Completed NCT00225615 - A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels Phase 3
Completed NCT02445521 - Testing of Four Home Phenylalanine Monitoring Prototype Devices N/A
Not yet recruiting NCT04302194 - Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development.
Completed NCT03419819 - Evaluation of PKU Sphere N/A
Completed NCT03167697 - Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia N/A
Recruiting NCT03856203 - Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
Completed NCT00104247 - Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels Phase 3
Recruiting NCT03777826 - Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU) N/A
Recruiting NCT05051657 - Evaluation of PKU Express Plus N/A
Recruiting NCT03952156 - Gene Therapy Clinical Study in Adult PKU Phase 1/Phase 2